Characterisation and cholesterol management in patients with cardiovascular events and/or type 2 diabetes in the Netherlands.
Over 40% of monitored patients in the Netherlands with established cardiovascular disease or type 2 diabetes mellitus and LDL-cholesterol levels > 1.8 mmol/L did not reach the target of 2.5 mmol/L, despite receiving lipid modifying treatment. This was concluded in a study recently published in Current Medical Research and Opinion. In this cross-sectional descriptive study, using linked pharmacy, hospitalisation and GP data from the PHARMO Database Network, characteristics and cholesterol management in 2010 of patients with high cardiovascular risk were determined. Findings suggest that management of hypercholesterolemia and other cardiovascular risk factors should be optimized to improve cardiovascular outcomes.
To read more, please click here.